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Abstract: Bacteria, although considered for decades to be antisocial organisms whose sole 
purpose is to find nutrients and multiply are, in fact, highly communicative organisms. 
Referred to as quorum sensing, cell-to-cell communication mechanisms have been adopted 
by bacteria in order to co-ordinate their gene expression. By behaving as a community 
rather than as individuals, bacteria can simultaneously switch on their virulence factor 
production and establish successful infections in eukaryotes. Understanding pathogen-host 
interactions requires the use of infection models. As the use of rodents is limited, for 
ethical considerations and the high costs associated with their use, alternative models based 
on invertebrates have been developed. Invertebrate models have the benefits of low 
handling costs, limited space requirements and rapid generation of results. This review 
presents examples of such models available for studying the pathogenicity of the  
Gram-negative bacterium Pseudomonas aeruginosa. Quorum sensing interference, known 
as quorum quenching, suggests a promising disease-control strategy since quorum-quenching 
mechanisms appear to play important roles in microbe-microbe and host-pathogen 
interactions. Examples of natural and synthetic quorum sensing inhibitors and their 
potential as antimicrobials in Pseudomonas-related infections are discussed in the second 
part of this review. 








For many years, scientists considered bacteria as autonomous unicellular organisms designed to 
proliferate under various conditions but with little capacity for interaction with each other and for 
collective response to environmental stimuli [1]. However, this view began to change around four 
decades ago, when emerging data provided evidence that cell-to-cell communication referred to as 
quorum sensing (QS) is a generic regulatory mechanism. QS enables bacteria to behave as a 
community and, via a density-dependent manner, launch a collective response to accomplish tasks 
which would be difficult, if not impossible, to achieve by an individual cell [2–4]. QS systems are 
widespread among many human opportunistic pathogens and are highly advantageous in situ where 
niche adaptation and symbiosis are important. Adaptation to morphological forms with better 
resistance to environmental threats is also aided by bacterial communication. Where establishment of 
successful infections is required, communication between bacteria enables them to coordinate the 
expression of virulence factors and overcome the defence systems of higher organisms including 
humans. This review discusses: (a) the QS-regulated virulence of the Gram-negative bacterium  
P. aeruginosa; (b) a number of infection models available for pathogen-host interaction studies; and  
(c) certain natural, and synthetic compounds, tested for their potential to rescue the infection models 
from P. aeruginosa toxicity. 
2. Quorum Sensing in Pseudomonas aeruginosa 
One of the most extensively studied QS systems is that of the Gram-negative opportunistic 
pathogen P. aeruginosa [5,6]. In this organism, the cell-to-cell communication is highly complex and 
consists of two hierarchically ordered, acyl homoserine lactone (AHL)-dependent QS systems referred 
to as the Las and the Rhl systems [7]. The Las system consists of the LasR transcriptional activator and 
of the AHL synthase LasI, which directs the synthesis of the N-3-oxo-dodecanoyl-homoserine lactone 
(3-oxo-C12-HSL) signal molecule [8]. Expression of a number of virulence factors including elastase, 
LasA protease, alkaline protease, and exotoxin A, is under the control of the Las system. Apart from its 
involvement in the regulation of various virulence factors, the Las system also regulates the expression 
of lasI itself, thereby creating a positive feedback loop [9] (Figure 1). By acting as an antagonist to the  
3-oxo-C12-HSL-LasR complex, RsaL binds to lasI promoter, thus repressing the expression of  
LasI [10]. Additionally, RsaL represses production of AHL-dependent virulence factors, such as 
pyocyanin and cyanide [10]. LasR expression is also tightly regulated via multiple factors involving 
Vfr and GacA (positive feedback) or QteE (negative feedback) [11–13]. 
Next to its function as a signal molecule, 3-oxo-C12-HSL also acts as a virulence determinant in its 
own right by modulating the responses of the host’s defence [7]. 3-oxo-C12-HSL down-regulates  
the host defence by inhibiting activation of dendritic- and T-cells [14], promotes apoptosis of 
neutrophils and macrophages [15], and provokes production of inflammatory cytokines in a  
calcium-dependent manner [16,17]. 
The Rhl system consists of the transcriptional activator RhlR and the RhlI synthase which directs 
the synthesis of the N-butanoyl-homoserine lactone (C4-HSL) signal molecule (Figure 1). Production 
of rhamnolipids, including elastase, LasA protease, hydrogen cyanide, pyocyanin, the stationary-phase 
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sigma factor RpoS, siderophores and the LecA and LecB lectins are all under the control of the  
Rhl system [9,18,19]. The R proteins of both systems show high fidelity for their cognate AHL and are 
not significantly responding to their noncognate AHL. In fact, 3-oxo-C12-HSL exerts only minimal 
RhlR activation whereas C4-HSL has no obvious effect on LasR. However, the Las and the  
Rhl systems are organized hierarchically in such a way that the Las system exerts transcriptional 
control over both rhlR and rhlI [7]. Despite this hierarchy, expression of rhlI and rhlR is not 
exclusively dependent on a functional Las system and the expression of genes such as lecA [20], 
pyocyanin, rhamnolipids and C4-HSL in a lasR mutant is delayed rather than abolished [21]. 
Transcriptome studies by Schuster [22] and by Wagner [23] brought to light the existence of Las- and 
Rhl-regulated genes and operons throughout the chromosome supporting the idea that the  
P. aeruginosa QS circuitry constitutes a global regulatory system. 
Figure 1. Quorum sensing (QS) in Pseudomonas aeruginosa. The hierarchical organisation 
of the two AHL-dependent QS systems in P. aeruginosa and its correlation with the  
P. aeruginosa quinolone signal (PQS) system is presented in the scheme below.  
(Skull represents virulence factor expression). 
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The Las and the Rhl systems are further modulated by the P. aeruginosa quinolone signal  
2-heptyl-3-hydroxy-4-quinolone (PQS) which increases the level of complexity to the QS network. 
PQS synthesis is controlled by both the Las and Rhl systems, whereas PQS itself controls  
the expression of RhlR and RhlI [24]. The PQS biosynthesis is aided by pqsABCD operon and 
regulated by the PqsR regulator, also referred to as MvfR. PqsR is a membrane-associated 
transcriptional activator that also regulates the production of elastase, 3-oxo-C12-HSL, phospholipase 
and pyocyanin [25]. Exogenous PQS was shown to induce expression of elastase B and of rhlI [6]. 
Aendekerk and co-workers [26] added to the understanding of PQS’s function by demonstrating that  
P. aeruginosa strains carrying mutations in the QS-regulated multi-drug efflux pump MexGHI-OpmD, 
that they were unable to produce wild type levels of either PQS or HSL and that these mutant strains 
were also unable to establish successful infections in mice and plant models. In addition, growth 
defects as well as altered antibiotic susceptibility profiles were observed for these strains. However, 
the phenotypes of these mutants could be restored to wild-type by the addition of exogenous PQS 
suggesting that the AHL/PQS-dependent QS-regulatory network plays a central role in coordinating 
virulence, antibiotic resistance and fitness in P. aeruginosa [26]. 
Since QS hierarchical order is observed in P. aeruginosa grown in rich medium, interesting 
behaviours can be seen under different growing conditions [27]. For instance, under phosphate-depletion 
conditions, the Las system seems to be dispensable for rhl and pqs activation. A recently published 
paper [28] suggested that amb genes in ambBCDE operon are responsible for the biosynthesis of  
2-(2-hydroxyphenyl)-thiazole-4-carbaldehyde (IQS), a molecule important in integrating quorum 
sensing and stress response. This system was further modulated by phosphate signalling, particularly 
PhoB. Production of IQS circumvents the las null mutation and activates QS- and virulence-associated 
genes in a las-independent manner [28]. This finding might explain the enigmatic phenomena where 
the las-defective clinical isolate maintains persistent infection, as for example in the pulmonary 
infection observed in cystic fibrosis (CF) patients. 
3. P. aeruginosa-Related Human Infections 
P. aeruginosa is a ubiquitous Gram-negative pathogen adapted to a variety of niches and has been 
described as one of the most common causes of nosocomial infections. This pathogen is capable of 
infecting virtually all tissues and nearly all clinical cases of P. aeruginosa infections can be associated 
with the compromise of host defence [29]. The high-risk groups for acquiring P. aeruginosa infections 
include severely-burned, HIV- and neutropenic-patients. CF patients also suffer from chronic  
P. aeruginosa infections, and this pathogen has been described as the major cause of mortality among 
this group [30,31]. Despite the aggressive antibiotic intervention, currently used in an attempt to clear 
the P. aeruginosa infection from CF patients, clearance is almost impossible to achieve. As a result, 
the majority of patients become persistently colonized by P. aeruginosa that leads to eventual death. 
Recent studies have also demonstrated P. aeruginosa to be the principal etiological agent of microbial 
keratitis (MK) associated with contact lens wear. Around 140 million people worldwide are contact-lens 
users and therefore at risk of developing a Pseudomonas-related MK infection which in extreme  
cases can result in complete sight loss [32,33]. In addition, colonization by P. aeruginosa  
has been described in cases of otitis, endocarditis, as well as in cases of acute and chronic non  
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CF-associated pulmonary infections [32]. A large variety of QS-regulated virulence factors including 
lipopolysaccharide, pili, proteases, exoenzymes, hydrogen cyanide, exotoxin A, and rhamnolipids are 
crucial for the establishment of a successful P. aeruginosa infection in the eukaryotic host [34]. 
4. Models Available for Studying the Pathogenicity of P. aeruginosa 
Understanding the pathogen-host relationship at both the cellular and molecular level is essential for 
identification of new targets and for development of new strategies to fight infection. Hence, molecular 
analysis of host-pathogen interactions would benefit from the use of model systems that allow  
a systematic study of the factors involved. A number of evolutionary divergent hosts such as 
mammalian cell lines [35], amoeba [36], nematodes [37], insects [38], and rodents [39] have been 
chosen for studying the pathogenesis of P. aeruginosa. Important experimental data that contributed to 
the understanding of P. aeruginosa pathogenesis have been derived, but none of the available models 
resemble the pathology of the disease as experienced by humans. Bigger and more complex animals, 
such as the CF pig model and the rodents, may not be feasible to use in studies due to the cost, space 
requirements and ethical considerations (Table 1). On the other hand, invertebrate model hosts,  
for example nematodes, have major drawbacks such as the lack of an adaptive immunity, a true 
complement system and an immune cell multilineage complexity, all of which are characteristics of 
humans. Hereby, we described animal models utilized for studying P. aeruginosa pathogenesis, followed 
by the feasibility of studying alternative drugs, such as quorum sensing inhibitors in these models. 










Silkworm Zebrafish Rodents 
Size 2–4 mm 1 mm 2.5 mm 2 cm 5 cm 6.4 cm 10 cm 
Generation 
time 









very easy very easy very easy easy easy easy difficult 
Costs low low low low low low high 
Space 
requirements 
minor minor minor minor minor minor major 
High 
throughput 
yes yes yes yes yes yes no 
Speed of 
outcome 
days days days days days days months 
Temperature 21–25 °C 15–25 °C 18–29 °C 25–37 °C 27 °C 29 °C 37 °C 
Innate 
immunity 
yes yes yes yes yes yes yes 
Adaptive 
immunity 
no no no no no yes yes 
Biological 
relevance 
potential potential potential potential potential confirmed confirmed 
Ethical 
considerations 
no no no no no yes yes 




Plants, due to their Toll-like receptors, are considered excellent alternative models for studying the 
pathogenesis of several microbes. The plant Arabidopsis thaliana was used as a model to study the 
virulence of a P. aeruginosa clinical isolate and the results indicated that the pathogen employs a 
similar subset of virulence factors to elicit disease in plants as it does in animals [40]. Lemna minor 
(duckweed) is widely used as a plant model for studies in plant physiology, genetics, ecology and 
environmental monitoring [41]. The reasons that make duckweeds a preferred model for such studies 
are their small size, their ability to rapidly undergo vegetative reproduction thus forming genetically 
uniform clones, and their high sensitivity to organic and inorganic substances. In 2010, Zhang and 
colleagues [41] developed an experimental model system using the duckweed as a simple and convenient 
host allowing for large scale studies on bacterial infections [41]. The authors also demonstrated the 
potential of using this model system to screen antibacterial compounds by co-cultivation of duckweeds 
with pathogenic bacteria. A small amount of P. aeruginosa PAO1 suspension was enough to elicit 
disease symptoms to the duckweed. These symptoms included collapsing of the fronds and inhibition 
of both reproduction and growth at day 1 after inoculation, followed by chlorosis and complete 
maceration at day 2–3 post-inoculation. Bacterial biofilm formation on the roots was detectable on day 
5 post-inoculation. PAO1 recombinant strains overexpressing quorum quenching enzymes (hPONs and 
Bacillus AiiA) had less profound effects on duckweed growth and displayed a reduced virulence at day 
5 post-inoculation compared to the wild-type [41]. Attenuated virulence could be also observed for 
PAO1 QS mutant strains of ∆rhlI, ∆lasI and ∆rhlI/∆lasI. Based on the above observations, it can be 
concluded that the duckweed model provides a highly sensitive and effective assay system for studying 
the pathogenesis of P. aeruginosa strains and it can possibly serve as a model system to test the 
functions of virulence genes of pathogenic bacteria in general [41]. Plant models face, however, 
limitations such as growth and size differences between individuals. 
4.2. Cell Lines 
At the cellular and molecular level, the bacterial pathogenesis mechanism and host response of cells 
have been studied using human cell lines. Using a microarray approach, Ichikawa et al. in 2000 [35] 
revealed alterations in gene expressions of A549 human lung carcinoma cells upon interaction with  
P. aeruginosa. An important gene encoding transcription factor IRF-1 (interferon regulatory factor 1), 
is upregulated in such a setting [35]. Exposure of IRF-1-deficient mice to lipopolysaccharide (LPS) 
and exotoxin A of P. aeruginosa showed reduction in production of tumor necrosis factor alpha (TNF-α) 
and interleukin 1 (IL-1), which indicates the importance of IRF-1 in eliminating P. aeruginosa infection [42]. 
The Caco-2 cell line (human intestinal epithelial cell) is sensitive to 3-oxo-C12-HSL, which causes 
apoptosis of the cells [16]. Transfection of PvdQ, an acylase active against 3-oxo-C12-HSL into these 
cells have proven to be effective to protect the cells from apoptosis [43]. This result indicates that 
quorum quenching can be a potential therapy for P. aeruginosa infection. A collection of numerous 
wild-type and Cftr −/− null cell lines, which can be cultured as either polarized or non-polarized, is 
currently available for mimicking CF infection in vitro. CF-lung-derived primary epithelial cells have 
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also added significant knowledge to the cell biology of CF [44–48]. However, using cell lines has a major 
drawback due to the lack of differentiation in phenotypes and lack of complexity in intact organs [44]. 
4.3. Dictyostelium discoideum 
The simplest organism that has been established as a model to study P. aeruginosa-host interactions 
is the social soil amoeba Dictyostelium discoideum [36,49,50]. The genome size of D. discoideum is 
about 34 Mb and the haploid nature of this genome offers D. discoideum a major advantage to other 
infection models as it allows the generation of a rich variety of mutants. P. aeruginosa virulence 
factors have been studied in D. discoideum by using simple plating assays comparing P. aeruginosa 
parental and mutant strains [51]. The Rhl system plays an essential role in controlling virulence of  
P. aeruginosa in D. discoideum infection models, since isogenic mutants deficient in Rhl system 
showed reduced virulence [36]. An important finding that supports the establishment of this amoeba  
as a pathogenesis model is the positive correlation between D. discoideum and a rat model infected 
with less virulent, MexEF-OprN-efflux pump-overproducer strain [36]. The contribution of phenazines 
and rhamnolipids to the killing of D. discoideum was examined and the results indicated that these 
factors are not responsible for P. aeruginosa virulence in D. discoideum [52]. Furthermore, purified 
pyocyanin, a phenazine that applies oxidative stress to eukaryotic cells, when added to D. discoideum 
at concentrations sufficient to kill mammalian cells, did not affect the viability of D. discoideum. This 
can be explained by the fact that D. discoideum is a soil organism that usually encounters a variety of 
different oxidative radicals. It is therefore expected that D. discoideum has evolved a wide range of 
mechanisms to deactivate such radicals [52]. Despite its many advantages as an infection model, the 
inability of Dictyostelium to survive at temperatures above 27 °C is a major drawback as P. aeruginosa 
and many other pathogens express most of their virulence traits at higher temperatures [53]. 
4.4. Caenorhabditis elegans 
One of the simplest invertebrate models for studying P. aeruginosa-host interactions is the 
nematode Caenorhabditis elegans normally found in the soil. The hermaphrodite C. elegans which  
can grow up to 1 mm in length possesses several advantages as a model. Examples of such advantages 
are its small size, the simple conditions it requires for growth and its rapid generation time. The 
nematodes are routinely propagated in the laboratory on petri dishes containing lawns of the auxotroph 
Escherichia coli OP50. Regardless of its simplicity, the innate immunity pathway of this nematode 
shares similarity with that of mammals. Antimicrobial proteins in C. elegans are produced via the 
PMK-1 p38 mitogen-activated protein kinase (MAPK) signalling cassette, which is related to the  
Toll-like receptor cascade found in mammals [54]. The well-developed genetic and molecular tools, as 
well as the complete genome sequence being available, contribute to the advantages of using  
C. elegans as a model for studies on bacterial pathogenesis [55–57]. 
Depending on the experimental conditions used, in agar-based assay, P. aeruginosa is known to kill 
C. elegans in four distinct ways. When grown on a rich, high-osmolarity medium, this pathogen causes 
lethal paralysis to the nematodes via a diffusible toxin, phenazine-1-carboxylic acid, in a pH-dependent 
manner [58]. However, when PA14 is grown on a minimal medium, the nematodes undergo a slow 
infection process that lasts several days and involves accumulation of bacterial cells in the nematode’s 
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intestines [59,60]. Yet another virulence mechanism was reported by Darby et al. [61]. This killing 
mechanism is the result of the action of hydrogen cyanide which requires the functionality of both the 
Las and the Rhl QS systems and causes a rapid neuromuscular paralysis [61]. In addition, “red death” 
of C. elegans occurs when the bacteria are grown in minimal medium with depletion of phosphate, 
where there is an activation of the phosphate signaling (PhoB)—the MvfR-PQS pathway of QS—and 
the pyoverdin iron acquisition system [62]. In a different setting termed as liquid killing assay,  
a recently discovered killing mechanism of P. aeruginosa is based on the siderophore pyoverdin that 
induces a hypoxia response and death in C. elegans in a liquid medium [63]. 
Despite its simplicity as an organism, C. elegans has significantly contributed to the understanding 
of both the pathogen’s and the host’s behaviour during the infection. It has been demonstrated that 
lethal paralysis of the nematodes by P. aeruginosa requires a functional copy of EGL-9, a protein 
strongly expressed in the nematode body wall and pharyngeal muscles [61]. Functional lasR seems to 
be only necessary for slow-killing and not for fast-killing of C. elegans by P. aeruginosa PA14 [56]. 
Even though C. elegans is a suitable and highly preferred model for studying the pathogenesis of  
P. aeruginosa, the nematode faces limitation in a lack of adaptive immunity. 
4.5. Drosophila melanogaster (Fruit Flies) 
The diptera Drosophila melanogaster has a long history as an animal model. Initiated by T.H. Morgan 
in 1910 as a model for studying heredity [64], by the year 2000 nearly 120 Mb of the fly’s genome had 
been successfully sequenced and annotated [65]. One of the advantages of this animal as a model for 
performing pathogenesis study is the shared similarity to the mammalian innate immune response.  
In both D. melanogaster and mammals, Toll family receptors signal through Rel family transactivators, 
mediating responses that are specific to different classes of pathogens [66]. D. melanogaster has an 
innate immune system similar to that of mammals and this makes it a favourable model for studying 
bacterial pathogenesis. 
Even though physical barriers and antimicrobial substances protect D. melanogaster from microbial 
attacks, pathogens such as P. aeruginosa are capable of penetrating the exoskeleton or the intestinal 
epithelium and cause an infection following what is referred to as the “physiological” or “natural” 
route of infection [66]. P. aeruginosa in particular can cause infection by two ways: (a) it can be 
distributed in the food used to feed D. melanogaster larvae or adult flies; or (b) it can be used for 
pricking the dorsal part of the fly thorax body cavity with a sharp needle previously dipped into  
P. aeruginosa suspension. However, the latter method is invasive and faces the disadvantage of 
interfering to some extent with the host defence. Depending on the route of inoculation, there seems to 
be a difference in the D. melanogaster defence response [67], as well as a difference in the requirement 
of virulence factors for full bacterial pathogenesis. P. aeruginosa needs fully functional Las and Rhl 
QS systems in the fly feeding method, but not in the pricking method, since most of the QS mutants do 
not show attenuation in lethality, except for RhlI mutant [68]. It has been found that in the fly feeding 
method, RhlR is crucial in counteracting the host’s cellular immune response, possibly at the early 
stages of infection [69]. Experiments by D’Argenio and coworkers [70] showed that the mutation in  
pil chp genes, important in twitching motility, reduced P. aeruginosa PAO1 virulence in the fly 
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pricking method. In addition, discovery of QscR function in LasI inhibition was aided by using this fly 
as an animal model for the assessment of mutants’ virulence [71]. 
When compared to alternative hosts for pathogen-host interaction studies, there are several practical 
limitations in using D. melanogaster as a model besides the inability of the fly to survive at 37 °C. 
Only a few strains of P. aeruginosa can infect via the “physiological route” and the administration of 
exact doses of either microorganisms or antimicrobial substances requires laborious techniques due to 
the small size of the fly. 
4.6. Galleria mellonella (Wax Moth) 
Larvae of the greater wax moth Galleria mellonella from Lepidoptera family are also used as  
a model to study human-pathogen interactions. Pathogenesis of numerous bacteria and yeasts are 
tested in this model, including Acinetobacter baumannii [72], Burkholderia cepacia complex [73], 
Enterococcus faecium [74], Enteropathogenic Escherichia coli [75], Legionella pneumophila [76], 
Listeria monocytogenes [77,78], Pseudomonas aeruginosa [79–83], Staphylococcus aureus [84], 
Streptococcus pneumonia [85], Aspergillus flavus [86], Aspergillus fumigatus [87],  
Candida albicans [88,89], Cryptococcus neoformans [90], and Fusarium spp. [91]. 
Compared to D. melanogaster, G. mellonella larvae are larger in size (250 mg), and therefore 
enable convenient injection of precise bacterial amounts into the hemocoel. In contrast to the C. elegans 
and the Drosophila models, a microscope is not required for the manipulation of G. mellonella. The 
ability to grow at 37 °C is another major advantage over the other invertebrates which cannot grow at 
this temperature [92]. Benefited by its large size, determination of bacterial LD50 is possible in wax 
moth larvae. Injection of bacterial mutants revealed the positive correlation between increased LD50 
and reduced virulence in burned mice models [93], indicating that this animal is an excellent model for 
studying relevant virulence factors in mammals. 
Introduction of bacterial lipopolysaccharide (LPS) to the wax moth induces expression of genes 
important in pathogen recognition and the ability of the host to fight the infection [94]. Interestingly, 
pre-exposure of the wax moth to non-lethal amounts of pathogen increases cellular and humoral 
response in a dose-dependent manner preparing the host to subsequent infection [87]. These data show 
that despite the absence of adaptive immunity, the animal is able to mount effective protection in 
response to prior pathogen exposure. A study conducted by Andrejko et al. in 2009 [83] showed  
that elastase B, a metalloprotease, from P. aeruginosa is able to degrade an antibacterial produced by 
G. mellonella during infection. This is in line with the observed role of elastase B in mammalian systems, 
in which the protease is able to destroy immune components, such as complements, cytokines, IgA and 
IgG [83]. Protease IV of P. aeruginosa is known to degrade apolipophorin-III (apoLp-III) from the 
hemocytes and fat body of G. mellonella [95]. Recently, G. mellonella larvae has been used as a model 
to study the efficacy of niclosamide, an antihelminthic drug, as a quorum sensing inhibitor (QSI) for  
P. aeruginosa [96]. Administration of niclosamide gave full protection to the larvae against acute  
P. aeruginosa infection [96]. 
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4.7. Bombyx mori (Silkworm) 
Studying bacterial pathogenicity and therapeutic effects of antibiotics becomes easier when a larger 
animal such as the silkworm, a larva of Bombyx mori, is used as an infection model. The body size of 
the instar larvae stage of the silkworm is 5 cm, which makes handling of this model easy. Injecting 
bacterial and drug samples into the hemolymph or the gut of the larvae is neither hard to perform nor 
monitor with the help of a marker [97]. The tissues responsible for drug metabolism can be isolated 
from the silkworm larvae allowing studies for the pharmacodynamics of certain compounds. A number 
of pathogenic bacteria including P. aeruginosa are able to kill silkworms with the 50% lethal dose  
of Pseudomonas exotoxin A being 0.14 µg·g−1. Moreover, GacA, which is important for full 
pathogenicity in burned mouse model, is also crucial in silkworm infection [98]. The silkworm model, 
like C. elegans, D. melanogaster and G. mellonella, lacks adaptive immunity, and thus, is not an ideal 
model for studies in which a simulation of immune responses as shown by humans is crucial [97]. 
4.8. Danio rerio (Zebrafish) 
A model host that combines the advantages of both the invertebrate and the rodent models is  
Danio rerio, the zebrafish. It has served as a model to study infections with a number of  
pathogens including Mycobacterium marinum [99], Salmonella enteric serovar Typhimurium [100], 
Edwardsiella tarda [101], S. aureus [102], Streptococcus iniae [103] and P. aeruginosa [104]. 
Zebrafish is 6.4 cm in size and relatively easy to handle. The embryos/larvae can be kept in a 96-well 
plate during the first five days of development. A single mating of a single adult pair of fish can 
generate about 200 embryos. The optical transparency of the embryos further adds to the advantages of 
zebrafish as a host model by allowing visualization of infection progression in real time [104]. 
Zebrafish has an innate as well as an adaptive immunity, both of which resemble the respective 
immunity of mammals. For example, zebrafish expresses Toll-like receptors, proinflammatory 
cytokines, complement proteins, and acute-phase response proteins. 
P. aeruginosa is able to establish lethal infections in zebrafish embryos, which are influenced by the 
inoculum size and by the presence of known virulence determinants such as lasR, mvfR and pscD, the 
developmental stage of the zebrafish embryos and the presence of immune cells. Clatworthy and 
coworkers [104] reported that a higher number of bacterial cells are required to achieve 100% lethality 
in embryos inoculated at 50 h post-fertilization (hpf) than in embryos inoculated at 28 hpf. These 
observations suggest that P. aeruginosa requires its full virulence arsenal in 50 hpf embryos in order to 
create a niche where it can survive and divide, and that 28 hpf embryos are less immunocompetent 
than 50 hpf embryos. 
4.9. Rodents 
Although the previously described models already gave valuable information about P. aeruginosa 
pathogenesis, further study in a complex organism is indispensable. Small mammals, especially 
rodents, are the preferable model to be used. With regards to QS, numerous studies have been 
conducted, either for understanding host-pathogen interactions or for QS inhibition. 
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4.9.1. Cystic Fibrosis Model 
P. aeruginosa infections are the major cause of mortality (80%) among CF patients. The respiratory 
tract of CF patients offers a convenient, yet challenging, environment for bacterial growth. Infection  
by P. aeruginosa in such an environment often starts by an intermittent colonization phase, and 
eventually develops into a chronic infection. It is of high importance to understand the pathogenesis of 
P. aeruginosa as presented in the CF lung environment. Because no natural animal models of CF exist, 
scientists developed a number of different CF mouse models to aid the understanding of the 
progression of P. aeruginosa infection in a CF lung. To date, transgenic mice with CF transmembrane 
conductance regulator (CFTR)-defects relating to CF and lung disease have been established. The 
currently available CF mouse models can be broadly classified into three main categories: (1) mouse 
models with a complete knockout of the Cftr gene which contain mutations that result in a complete 
loss of function [105]; (2) mouse models retaining the potential for reversion to wild-type, generated 
using an “insertional strategy” into the target gene [106]; and (3) the later-in-time generated 
recombinant CF mouse-models which contain clinically relevant mutations in Cftr, created by 
introducing specific human mutations, including the ∆F508 and G551D into the equivalent mouse loci. 
These mouse models have been extensively reviewed elsewhere [44,107,108]. Although mouse models 
have been widely used and have provided precious information about CF progression, two larger 
animal models were developed that closer resemble the disease manifestation as observed in humans. 
The Cftr knockout pig and ferret develop a CF manifestation in multiple organs including the lungs, 
pancreas and gastrointestinal tract [109]. 
The first P. aeruginosa chronic pulmonary infection was developed in rats, using bacteria-containing 
agarose beads, introduced via the intratracheal route [110]. In 1987, Starke et al. [111] adapted the  
P. aeruginosa-embedded agar beads method to develop infection in mice, and they showed similar 
histopathological effects as in larger animals, such as rats, guinea pigs and cats [111,112]. 
Replacement of agarose with seaweed alginate has been performed in a chronic bronchopulmonary 
infection model developed by Pedersen et al. [113]. Agarose, agar or seaweed alginate act as artificial 
biofilms, retaining the bacteria in the airways and protecting them from mechanical clearing [114]. It is 
also possible to use a mucA mutant, making artificially embedded material redundant, since this isolate 
shows a hyperproduction of alginate [115]. 
Using Cftr −/− mouse model, Hoffman et al. [116] examined the effect of azithromycin towards 
chronic lung P. aeruginosa infection. Azithromycin is known to be active against Gram-positive 
bacteria, and a study revealed that the sub-MIC concentration of azithromycin is capable of  
inhibiting QS-regulated virulence factors [117]. In the abovementioned study, it is proven that 
azithromycin also inhibits alginate production and increases bacterial susceptibility of the host’s 
complement system [116]. 
4.9.2. Burn Wound Model 
Patients with burn wounds are at great risk of acquiring bacterial infections from pathogens such as 
P. aeruginosa. Local colonization of this bacterium may develop into systemic sepsis, which is often 
associated with a high degree of mortality. In order to understand the pathophysiology of the bacterial 
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infection, P. aeruginosa-infected burned mouse models have been developed [118–122]. Topical 
inoculation of P. aeruginosa PAO1 in the burn wound induced sepsis shock indicated by elevated 
levels of pro-inflammatory and anti-inflammatory cytokines [119]. The importance of QS in  
P. aeruginosa pathogenicity in burn wounds was confirmed by the virulence attenuation of mutations 
in lasI, lasR, rhlI, lasI/rhlI [118] and gacA genes [121]. The inability of lasR and lasI/rhlI mutants  
to spread within the wound and cause septicemia is possibly caused by the low level of QS  
associated-virulence other than lasA, lasB, toxA and rpoS [118]. High incidence of bacterial infection 
in burn wounds, along with the increasing rate of antibiotic-resistance strains, makes the finding  
of novel antibacterials a crucial necessity. However, the main obstacle in studying potential 
antimicrobials is that these animal models often develop complications which are burn wound related, 
rather than caused by bacterial pathogenesis [120]. One of the well-known QSI, garlic extract, showed 
an in vitro inhibition of biofilm formation in burn wound isolates of Gram-negative bacteria, including 
P. aeruginosa [123]. In vivo examination of garlic, especially in ointment dose form, will be beneficial 
for its development as an antivirulence substrate. 
4.9.3. Foreign Body Implants Model 
Another group of patients at great risk of P. aeruginosa-related infections are those who make use 
of prosthetic indwelling devices such as catheters, tracheostomy tube, and cardiac pacemakers [124]. 
Once the biofilm-forming bacteria, such as P. aeruginosa, colonize the foreign bodies, removal of the 
implant is usually the only alternative, since the biofilm is almost impossible to eradicate [125,126]. 
The protocol for in vivo study of antibacterial candidates using intraperitoneal foreign-body infection 
in a mouse model has been established [125–127]. In these studies, application of QSI (furanone C-30, 
ajoene or horseradish extract) solely increased bacterial clearance by the host innate immune system as 
compared to placebo treatment. Interestingly, synergistic antimicrobial efficacy was observed in 
administration of QSI in combination with tobramycin [126]. Bacterial biofilm is a compact structure, 
tolerant to antibiotics and to the bactericidal activity of polymorphonuclear cells (PMNs) [128].  
QSI not only negatively influences biofilm formation, but also disrupts production of QS-mediated 
virulent factors, including rhamnolipids which act as a “shield” against PMNs. Therefore, with  
QSI-treatment, the biofilm is more susceptible to tobramycin and, at the same time, PMNs are more 
active against the pathogen [125,126,128]. 
4.9.4. Urinary Tract Infections (UTIs) Model 
P. aeruginosa is a common pathogen found in nosocomial catheter-associated urinary tract 
infections (UTIs). The tendency of this pathogen to form biofilms often leads to chronicity and 
recurrence of the infection [129]. A significant antibiotic resistance is rarely found in UTI cases, 
possibly because the urine sample used in in vitro assay only represents planktonic populations, 
without considering phenotypically distinct bacteria within biofilms [130]. Oral administration of 
garlic extract as a prophylactic treatment to mouse models prior to renal P. aeruginosa biofilm 
challenge significantly reduced bacterial colonization [129]. Azithromycin treatment either orally or 
intravenously to P. aeruginosa-associated UTI mouse model resulted in bacterial clearance [131].  
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This effect might be attributed to the inability of the bacteria to form mature biofilms in the presence 
of azithromycin [131]. 
5. Quorum Quenching 
Scientists are focussing on three main approaches by which one could interfere with bacterial QS: 
(a) interfering with signal generation; (b) preventing signal accumulation; and (c) prohibiting signal 
reception (for a review, see references [132–134]). In this review, we discuss the current findings of 
QSIs using the above-mentioned interference methods in the three QS systems of P. aeruginosa. 
A great amount of work has been performed in order to elaborate the complex QS system of  
P. aeruginosa. The gained knowledge leads to the possibility of finding alternative targets, such as 
pathway inhibition, for the development of novel therapies. It is suggested that the acyl group of the 
HSL of P. aeruginosa is provided by the fatty acid biosynthesis (Fab) pathway, consisting of a set of 
Fab proteins. Interference of this pathway, as performed by triclosan in inhibiting FabI to complete the 
fatty acid elongation, resulted in less production of both 3-oxo-C12-HSL and C4-HSL [135]. Yet 
another strategy was implemented to provide analogues of precursors important in P. aeruginosa signal 
generation. In a multistep reaction, condensation of anthranilate and β-keto-decanoic acid resulted in 
formation of PQS molecules. Addition of methyl anthranilate, as an analogue of anthranilate, inhibited 
the production of both PQS and elastase without affecting the bacterial growth [136]. Lesic and 
colleagues [137] introduced further potent analogues of anthranilate, termed as 6FABA, 6CABA, and 
4CABA. These compounds inhibit the production of 4-hydroxy-2-alkylquinolines (HAQs), the 
intermediate in PQS production, and are proven to be effective in hampering P. aeruginosa infection in 
burned mouse models [137]. 
After the signal molecules have been synthesized and secreted into the extracellular medium, it is 
possible to interfere with their accumulation either by completely degrading or by inactivating them. 
Two types of enzymes able to degrade the AHL signal molecules have been described up to this date: 
(a) AHL-lactonases and (b) AHL-acylases. The least studied quorum quenching enzyme, the 
oxireductase, belongs to a class of enzymes capable of inactivating AHL without degradation, but via 
modification. Thus, these enzymes limit the amount of bioactive AHL present in the environment. 
AHL-lactonases hydrolyse the lactone ring in the homoserine moiety of AHLs without affecting  
the structure of the signal molecule any further. One of the first described and extensively studied 
AHL-lactonases is the AiiA produced by the Gram-positive Bacillus sp. 240B1 [138]. AiiA, when 
expressed in P. aeruginosa PAO1, resulted in a decrease of elastase, rhamnolipids, pyocyanin and 
cyanide production levels [139]. Oral administration of AiiA via food supplementation showed a 
reduction of virulence, since Aeromonas hydrophila infection in zebrafish was attenuated [140]. 
Despite the promising outcomes of signal degradation by AHL-lactonases, an important drawback of 
this approach is presented by the reversibility of the lactonolysis reaction at acidic pHs, regardless of 
the method used to open the lactone ring [141]. 
The second class of enzymes, known as AHL-acylases, is also employed by bacteria for the 
degradation of the AHL signal molecules. The bacterium Variovorax paradoxus VAI-C was the first 
host in which an AHL-acylase enzyme was detected [142]. Today, at least five AHL-acylases produced 
by a diverse range of bacteria have been extensively studied and shown to attenuate virulence in  
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P. aeruginosa. These are the AiiD from Ralstonia eutropha [143], the AhlM from Streptomyces sp. [144], 
and the PvdQ, QuiP and HacB produced by P. aeruginosa PAO1 [145,146]. All of the above 
mentioned enzymes hydrolyse the amide bond between the acyl chain and the homoserine lactone in 
the AHL molecule, thus generating the corresponding free fatty acid and the homoserine lactone. 
In 2003, the AiiD acylase from Ralstonia was described and when expressed in P. aeruginosa 
PAO1 it exhibited profound effects on the pathogen’s virulence [143]. In the presence of AiiD HSL-acylase, 
the swarming ability of P. aeruginosa was reduced. In addition, there was a significant reduction in the 
production of virulence factors such as elastase and pyocyanin [143]. The most important outcome of 
the study performed by Lin et al. [143] was the demonstration that AiiD can attenuate the virulence of 
P. aeruginosa in the C. elegans infection model where it was shown to rescue the nematodes from 
lethal paralysis. The latter observation hints on the possibility that this type of enzymes might be,  
in the future, effectively used as antimicrobial therapeutic agents. 
One of the AHL-acylases in P. aeruginosa, PvdQ, has been studied in depth. It has been previously 
reported that the in vitro substrate specificity of purified PvdQ includes AHLs with side chains ranging 
in length from 11 to 14 carbon atoms [147]. The specificity of the PvdQ does not seem to be influenced 
by the substituent at the 3' position of the N-linked acyl side chain [148]. In the presence of purified 
PvdQ, the accumulation levels of the 3-oxo-C12-HSL in growing P. aeruginosa cultures are severely 
reduced and the degradation of 3-oxo-C12-HSL by the protein leads to a delay in the production of 
PQS. Production and accumulation of C4-HSL are not influenced by the presence of PvdQ, confirming 
the inactivity of the acylase towards AHLs with short side chains. Extracellular addition of the protein 
and intracellular production of the enzyme produced the same results. In both cases, the production 
levels of the virulence factors elastase and pyocyanin significantly dropped [147]. Since both 
expression of PvdQ in the bacterium and administration of the protein to growing P. aeruginosa 
cultures resulted in quorum quenching in vitro, the nematode C. elegans was used as an infection 
model to monitor the pathogenicity of P. aeruginosa [149]. It has been reported that PvdQ, when 
overproduced in the bacterium, rescues more than 70% of the nematodes from lethal paralysis. Under 
different conditions which result in the slow death of the nematodes by bacterial accumulation in their 
gut, morphological appearance examination indicated that the development of disease-like symptoms 
is occurring at a slower rate when PvdQ is overproduced [149]. The importance of this AHL-acylase in 
interfering with QS, and in subsequently attenuating the virulence of P. aeruginosa, is further 
supported by data showing that deletion of pvdQ leads to higher bacterial toxicity [149]. 
The effect of the oxireductase enzyme has been studied by Bijtenhoorn et al. [150]. Oxireductase is 
a NADP-dependent reductase isolated from soil metagenome and designated as Bpi09. It was 
suggested that this enzyme might not only reduce 3-oxo-C12-HSL, but also 3-oxo-acyl-ACP, thus 
interfering with the synthesis of the signal molecule itself. Expression of Bpi09 in P. aeruginosa 
PAO1 leads to the reduction of pyocyanin production, as well as in decreased motility and poor 
biofilm formation. Furthermore, in vivo analysis using C. elegans paralysis assay, reveals the ability of 
Bpi09 to suppress virulence production in P. aeruginosa [150]. 
Enzymatic degradation of PQS signal molecule is also feasible, by the 3-Hydroxy-2-methyl-4(1H)-
quinolone 2,4-dioxygenase (Hod) of Arthrobacter nitroguajacolicus strain Rü61 [151]. This enzyme 
catalyses the cleavage of PQS into carbon monoxide and N-octanoylanthranilic acid. Although purified 
Hod is shown to be active in the inhibition of PQS-signalling in vitro, the efficiency of the enzyme is 
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reduced by the presence of exoprotease in the culture supernatant. PQS inactivation via pqsA mutation 
or addition of purified Hod showed virulence attenuation in planta using lettuce leafs [151]. 
The third approach of interfering with bacterial QS is by blocking the binding of the signal to the 
receptor, or by destroying the receptor protein. QSIs in this group are the ones that compete with AHLs 
for the receptor-binding site and must meet certain requirements. First, the QSI must be a molecule of 
a low-molecular-mass and second, it must be able to significantly reduce the expression of genes that 
are under QS control [141]. Equally important is the necessity for the QSI to withstand a possible 
clearance or degradation by the host, as well as the necessity for this molecule to be nontoxic to the 
infected host. Many attempts have been made to identify possible QSIs. Over the years, a number of 
synthetic as well as natural compounds have been identified as potential candidates and have been 
screened for their ability to reduce the pathogen’s virulence. The positive correlation of several QSIs 
effect in C. elegans and mice model is presented in Table 2. 
Table 2. Natural and synthetic quorum sensing inhibitors tested in C. elegans and  
mouse-models. (N.D.): Not defined. 
QSIs C. elegans Mouse-models References 
AHL-acylases + N.D. [143,149] 
Furanones + + [125,126,152–154] 
Garlic + + [126,129,155–157] 
4-NPO + N.D. [155] 
Azithromycin N.D. + [116,131,158] 
Patulin N.D. + [159] 
5.1. Natural QSIs 
Plants including tomato, pea seedlings, garlic, chili, water lily, soybean, carrots, crown vetch, 
gingko biloba, horseradish, rosemary, Tasmanian blue gum, brown algae (Ascophyllum nodosum), 
Ayuverda spice clove (Syzigium aromaticum), Dalbergia thiocarpa and Terminalia chebula, all 
produce QSIs [155,160–166]. Some bioactive compounds have been characterized as responsible for  
the quorum sensing inhibitor properties. Examples of such compounds are ajoene  
(4,5,9-trithia-dodeca-1,6,11-triene 9-oxide) in garlic extract [126,156], eugenol in clove extract [165] 
iberin in horseradish extract [161] and ellagic acid derivatives in Terminalia chebula [166]. The 
abovementioned natural QSIs have been verified to reduce production of virulence determinants such 
as the rhamnolipid and pyocyanin of P. aeruginosa in vitro. Some of these QSIs have been tested  
in vivo, using C. elegans, D. melanogaster or even a mouse model. It has been reported by Bjarnsholt  
and colleagues [141] that in vitro, garlic-treated P. aeruginosa biofilms are not only susceptible  
to tobramycin, but also to PMNs. These observations are identical to the ones made by  
Rasmussen et al. [159] when they exposed P. aeruginosa biofilms to patulin derived from the fungal  
Penicillium coprobium. 
Efficacy of garlic extract was not only observed in C. elegans [155], but also in mouse models 
infected with P. aeruginosa via different routes. Oral administration of fresh garlic extract prior to 
mice urinary infection results in significantly lower renal bacterial counts and in protection of the 
mouse kidney from tissue destruction [129]. Furthermore, the garlic treatment was clinically tested and 
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showed a lung function improvement in CF patients. However, the sample group was too small to give 
a statistically significant clinical outcome [167]. 
5.2. Synthetic QSIs 
Production of synthetic AHL antagonists by modifying the AHL structure has been studied. 
Synthesis of AHL autoinducer analogues by Persson et al. [168] has shown that compounds in which 
the C-3 carbon on the side chain is replaced with sulphur block activity of LuxR and LasR proteins. 
Replacement of the head part of 3-oxo-C12-HSL with different aromatic rings as well as modification 
in the tail part showed an inhibition of LasR activity [169–171]. Screening of potential QSIs from 
synthetic compound library reveals the presence of PD12 (tetrazole with a 12-carbon alkyl tail) and  
V-06-018 (phenyl ring with a 12-carbon alkyl tail) as 3-oxo-C12-HSL analogues [172]. Based on the 
design of a previously synthesized compound, named N-octanoyl cyclopentylamide (C8-CPA),  
Ishida et al. [173] successfully produced N-decanoyl cyclopentylamide (C10-CPA); a stronger QSI that 
interferes with expression of P. aeruginosa virulence factors regulated by the las and rhl  
quorum-sensing systems. Synthetic S-phenyl-L-cysteine sulfoxide and diphenyl disulfide are not only 
proven to inhibit P. aeruginosa QS in vitro, but also in vivo, as seen in the Drosophila infection model [174]. 
Owing to the presence of high-throughput screening technique, numerous QSIs from natural 
sources have been found and characterized. However, isolating the compounds from its endogenous 
source is not a practical method, especially if an endangered species is utilized. Therefore, attempting 
to produce synthetic compounds is a better approach. Based on the chemical structure of natural 
furanones, such as that of Delisea pulchra, a synthetic derivative referred to as furanone C-30 was 
generated. The classification of C-30 as a QSI was supported by a DNA microarray analysis showing 
that 80% of the furanone repressed genes in P. aeruginosa are also QS-controlled [152]. C-30 
influenced the production of exoproteases and pyoverdin. Injection of 7 µM furanone C-30 every 8 h 
for a six-day period into P. aeruginosa-infected mice resulted in a ~3 logs reduction of bacterial cell 
numbers in the infected lung tissues [152]. In addition, a different study by Wu et al. [153] showed that 
furanone C-30, as well as the synthetic furanone C-56, significantly increased the survival time of mice 
with lethal P. aeruginosa infections, assisted bacterial clearance by the host and reduced the lung 
pathology. Thus, synthetic furanones appear to be promising novel antimicrobial agents. Worries about 
toxicity, however, remain. 
Using QSI selector systems, Rasmussen et al. [155] identified a number of QSI compounds with 
structures unrelated to the signal molecules. Examples of such compounds are the 4-nitro-pyridine-N-oxide 
(4-NPO), indole, p-benzoquinone, 2,4,5-tribromoimidazole, and 3-nitrobenzene sulphone amide.  
Of these, 4-NPO proved to be the most effective downregulating 37% of the QS-controlled genes in  
P. aeruginosa as demonstrated by DNA microarray-based transcriptomics. A search for the specific 
genes affected revealed a distinct specificity for the RhlR as the target for 4-NPO [141]. In the 
presence of 4-NPO, the mortality of C. elegans fed on P. aeruginosa dropped to 5%. The other potent 
QSI found in this study [126,156] was the garlic extract, which as explained earlier, contains ajoene as 
its bioactive compound. Synthetic ajoene showed synergistic antimicrobial effect with tobramycin on 
biofilm degradation in vitro, and promoted clearance of P. aeruginosa pulmonary infection in mice as 
compared to the placebo-treatment group [156]. 
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(R)-Bgugaine, a pyrrolidine alkaloid from Arisarum vulgare is proven to have antifungal and 
antibacterial activity. Application of synthetic norbgugaine (demethylated bgugaine) to P. aeruginosa 
showed an inhibition of QS-regulated virulence factors, including pyocyanin, rhamnolipid,  
LasA protease as well as a reduction of swarming motility and biofilm production [175]. 
Azithromycin influences, by its presence, 10.4% of the genes of the general QS regulon of  
P. aeruginosa. Nalca et al. [176] reported that azithromycin-treated P. aeruginosa cultures exhibit  
a reduced expression of various proteins which are required for flagellum biosynthesis. The result was 
a reduced flagellum-driven motility on swimming agar plates. The same group also observed that in 
the presence of azithromycin, P. aeruginosa undergoes an impaired oxidative stress response which 
might account for the significant reduction of P. aeruginosa viability after prolonged incubation with  
sub-MIC (minimum inhibitory concentration) of azithromycin [176]. The in vivo effect of 
azithromycin was revealed using a mouse model of chronic P. aeruginosa lung infection. Treatment of 
such mice with azithromycin significantly improved the clearance of alginate biofilms and reduced the 
severity of lung pathology [114]. In a one-year period, 45 CF patients with chronic P. aeruginosa 
infection received a low-dose azithromycin treatment as an integral part of their routine  
treatment [177]. The study resulted in an improvement of lung function and reduction of mucoid 
strains of P. aeruginosa in sputum sample. Furthermore, a pilot clinical trial of azithromycin has been 
carried out in randomized, intubated colonized patients, who are at risk of rhamnolipid-dependent 
ventilation-associated pneumonia (VAP) [178]. Reduced occurrence of VAP was observed in the 
azithromycin-treated group, suggesting that virulence inhibition is a promising strategy. All these 
observations raise the hopes that administration of azithromycin to patients suffering from  
P. aeruginosa-related infections, including CF, might help in the management and possible eradication 
of these infections. 
6. Discussion 
Studying human diseases requires testing of microorganisms in appropriate model systems. 
Traditionally, mammalian models have been the first choice for human pathogen studies, as they show 
similarities to human responses to infection. However, negative factors have to be taken into 
consideration. For instance, the large number of animals required to be sacrificed for such studies is by 
itself ethically questionable. In addition, the large size of animals, and thus, the space requirements 
associated with it, as well as the costs and the time required for the execution of experiments, resulted 
in the necessity for the establishment of alternative models for studying bacterial pathogenesis.  
To overcome these problems, laboratories have employed models such as C. elegans, silkworms,  
D. melanogaster and zebrafish for studying pathogen-host interactions. Using these genetically 
tractable models, a lot of knowledge has been gained about the mechanisms employed by  
P. aeruginosa for the establishment of infections. 
The pathogenesis of P. aeruginosa in evolutionary distant hosts revealed conserved virulence 
factors required in causing an infection in multihost systems. Hence, interference of the central system 
controlling this virulence production, such as deactivation of QS, will lead to bacterial attenuation, 
which may be observed in different hosts. Hitherto, three QS circuits are studied thoroughly: the Las, 
the Rhl and the PQS system. Several—but not all—key proteins in each of the QS systems are shown 
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to be indispensable in the establishment of infection of a host model, in a particular experimental 
setting. LasR, for example, is important in a slow-killing, and not in a fast-killing, assay of C. elegans. 
This regulator is also essential for the full virulence required for zebrafish infection. Bacterial 
colonization occurring in the slow-killing assay in C. elegans is also occurring in a similar manner in 
zebrafish embryo infected with P. aeruginosa [59,104]. Mutation of GacA, the response regulator of 
the GAC two-component system, leads to a reduced bacterial virulence not only in A. thaliana,  
C. elegans, G. mellonella and silkworm, but also in burned mouse model [37,93,98,121,179]. 
The positive correlation of the animal models’ response in these observations strengthens the 
credibility of non-mammalian hosts in studying bacterial pathogenesis. The important applications for 
these findings are that fundamental studies and drug development can be initiated from even the 
simplest animal models. Since high-throughput screening and whole-body infection systems are 
feasible in invertebrates, analysis of large libraries of drug candidates with regards to interfering with 
host pathogen-interaction is possible to perform [180]. Although eventual pharmacokinetics analysis in 
higher animal models is irreplaceable, preliminary studies in invertebrates can be an effective start. 
Increasing emergence and prevalence of antibiotic-resistant bacteria makes the currently available 
antibiotic less effective. While the need of novel antibacterial is alarming, screening and development 
of the potential drug candidate is a laboriously long process, which could take 20 years before the 
drugs would be allowed on market. Therefore, to circumvent this issue, the study of the novel 
antibacterial has to be constantly performed. Targeting virulence attenuation, instead of killing the 
pathogen, is considered an attractive alternative, since it gives less pressure to develop resistance. 
Using this approach, quorum quenching in P. aeruginosa serves as an excellent candidate, as it has 
been extensively studied and also proved to be active in eradicating bacterial infection in vivo. 
QS in P. aeruginosa consists of complex molecular machineries, and its activity is induced by the 
environmental stimulus. Hence, exposure to different conditions during development of P. aeruginosa 
infection leads to different activity levels of QS, since the importance of QS is dissimilar in each stage. 
QS seems dispensable in P. aeruginosa acute infection, where the type III secretion system which is 
negatively regulated by QS plays a dominant part [181]. On the other hand, QS is proven to be 
involved in biofilm formation, verifying its importance in the initial steps of persistent infection. 
Deactivation of AHL-dependent QS, either by mutation of LasRI and RhlRI or by addition of QSIs, 
results in a thin, flat biofilm structure of P. aeruginosa mutant, which is susceptible to antimicrobial 
challenge and phagocytosis by PMNs [128,152]. Biofilms are thought to be an ideal configuration for 
persistent infection, since they provide protection from both antibacterials and the host’s immune 
system. Within biofilm populations, diverse bacterial entities can be found due to the nutrient and 
oxygen gradient along the biofilm matrix. 
Genotypic and phenotypic alterations occur during the progression of persistent infections such as 
those observed in CF patients. Mutation in the QS systems—mostly in the Las and Rhl system—are 
frequently found in the chronic CF isolates. Despite this, however, the presence of 3-oxo-C12-HSL,  
C4-HSL, PQS and QS-associated virulence factors such as rhamnolipids in the sputa sample, indicates 
that some QS activity still remains [30,182,183]. This phenomenon could be due to the existence of 
wild type bacteria within the population or due to the activation of a las-independent pathway operated 
under the PQS system or conceivably under a newly discovered IQS signal molecule. Although this 
knowledge reveals the possibility of targeting PQS for chronic infection, it was observed, in vitro, that 
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reducing PQS levels leads to the increase of cytotoxin secretion by the type III secretion system. 
Therefore, the delivery of PQS inhibitor should be coupled with type III blocking therapy and 
appropriate antimicrobials [184]. 
In a search for compounds that can act as QSI, many candidates, natural or synthetic, have been 
revealed. Examples of natural QSIs include the halogenated furanones produced by D. pulchra and 
garlic extracts, which have been shown to effectively interfere with the QS-related P. aeruginosa 
pathogenicity in the C. elegans and mouse infection models. The availability of appropriate infection 
models makes screening for compounds that result in the rescue of such models from threatening  
P. aeruginosa infections possible. However, the goal of finding an infection model that will be able to 
simulate bacterial infection precisely as seen in humans is yet to be reached. In addition, despite the 
successful application of a number of QSI in such models, their use in humans must be judged with 
care. Even though garlic-treatment has been successful in clearing P. aeruginosa infections in  
C. elegans and mice, it is far from becoming an easy treatment in clinical cases of  
P. aeruginosa infections acquired by humans. The low level of active compound in garlic requires a 
person to take 50 garlic bulbs a day to achieve an effective treatment, and as a result, patients tend to 
withdraw from such treatment. Although ajoene, the bioactive compound in garlic, has been successfully 
synthesized and proven to be efficacious in eliminating P. aeruginosa infection in vitro and in vivo,  
it must be first proven to be clinically safe before it can be approved as an applicable drug for humans. 
7. Conclusions 
It can therefore be concluded that generating a top model for studying host-pathogen interactions 
and for identifying appropriate QSIs of clinical importance is challenging and has yet not been reached. 
Modulating QSIs to aid their successful application in clinical treatment of P. aeruginosa-infected 
patients and finding a model in which the outcomes of testing such compounds can be directly 
correlated to humans remain important topics at which further research efforts should be directed. 
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